Oral prodrug combinations of 5-fluorouracil precursors in capsule form for gastrointestinal and other solid tumors. Prescribed in ambulatory care by gastroenterologists and oncologists. Produced by Japanese and global pharma entities, acquired by procurement teams for community and academic medical centers.